Literature DB >> 22658799

A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups.

Ramishetti Srinivas1, Arup Garu, Gopikrishna Moku, Sachin B Agawane, Arabinda Chaudhuri.   

Abstract

Dendritic cells (DCs) pulsed/transduced with tumor-associated or viral antigens have shown promise in combating cancer and infectious diseases. Despite significant progresses, development of a biologically safe DC-based genetic immunization (DNA vaccination) system capable of providing truly long-lasting protective immunity remains a significant scientific challenge. Here we show that immunization with autologous DCs pre-transfected with electrostatic complexes (lipoplexes) of a plasmid DNA encoding melanoma tumor associated antigen and liposomes of two lysinylated cationic amphiphiles with mannose-mimicking quinic and shikimic acid head-groups provides long-lasting (300 days post tumor challenge) protective immunity with significant memory response (more than six months after the second tumor challenge) in more than 80% immunized mice. The presently described non-viral ex vivo DC-transfection system may be exploited in inducing long-lasting immune response in DC-based genetic immunization.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658799     DOI: 10.1016/j.biomaterials.2012.05.006

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

1.  Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination.

Authors:  Yu-Zhe Chen; Gui-Xin Ruan; Xing-Lei Yao; Li-Ming Li; Ying Hu; Yasuhiko Tabata; Jian-Qing Gao
Journal:  Pharm Res       Date:  2013-02-01       Impact factor: 4.200

Review 2.  Micro- and nanoparticulates for DNA vaccine delivery.

Authors:  Eric Farris; Deborah M Brown; Amanda E Ramer-Tait; Angela K Pannier
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-04

Review 3.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

Review 4.  Nanomaterials for cancer immunotherapy.

Authors:  Wantong Song; Sara N Musetti; Leaf Huang
Journal:  Biomaterials       Date:  2017-09-17       Impact factor: 12.479

5.  Size-Dependent Antibacterial Immunity of Staphylococcus aureus Protoplast-Derived Particulate Vaccines.

Authors:  Xuelian Fan; Fei Wang; Xin Zhou; Bin Chen; Gang Chen
Journal:  Int J Nanomedicine       Date:  2020-12-17

6.  Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response.

Authors:  Arup Garu; Gopikrishna Moku; Suresh Kumar Gulla; Arabinda Chaudhuri
Journal:  Mol Ther       Date:  2015-12-15       Impact factor: 11.454

Review 7.  Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies.

Authors:  Michael Lim; Abu Zayed Md Badruddoza; Jannatul Firdous; Mohammad Azad; Adnan Mannan; Taslim Ahmed Al-Hilal; Chong-Su Cho; Mohammad Ariful Islam
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

Review 8.  Nanoparticle cancer vaccines: Design considerations and recent advances.

Authors:  Jingjing Liu; Lei Miao; Jiying Sui; Yanyun Hao; Guihua Huang
Journal:  Asian J Pharm Sci       Date:  2019-12-31       Impact factor: 6.598

Review 9.  Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.

Authors:  Chi Zhang; Yifan Ma; Jingjing Zhang; Jimmy Chun-Tien Kuo; Zhongkun Zhang; Haotian Xie; Jing Zhu; Tongzheng Liu
Journal:  Molecules       Date:  2022-03-17       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.